Patent Verwendung von Blockern der NKG2D-Rezeptor-/NKG2D-Liganden-Interaktion bei Autoimmunerkrankungen

Basic data

Title:
Verwendung von Blockern der NKG2D-Rezeptor-/NKG2D-Liganden-Interaktion bei Autoimmunerkrankungen
Reference number (DPMA):
10 2004 042 894.8
Primary registration:
30/08/2004
Abandoment:
01/03/2017 (expired)

Inventors

Friese, Manuel
formerly Universität Tübingen
Schreiner, Bettina
formerly Universität Tübingen
Steinle, Alexander
formerly Universität Tübingen
Faculty of Medicine
University of Tübingen
Weller, Michael
formerly Universität Tübingen
Wiendl, Heinz
formerly Universität Tübingen

Local organizational units

Faculty of Medicine
University of Tübingen

National patents

PCT Registration

Registration date:
08/08/2005
Registration number:
PCT/EP2005/008579

Nationalizations

Patent familiy:
10 2004 042 894.8, EP05773900

EP05773900
European Patent Office
08/08/2005
03/03/2017 (expired)
Help

will be deleted permanently. This cannot be undone.